Leading pharmaceutical companies such as Eli Lilly, Merck,
Baxter, GlaxoSmithKline, Genentech, Pharmacia and AstraZeneca have
all used the modular approach for their new manufacturing buildings
worldwide.
Since 2011, Pharmadule is owned by Morimatsu Group Japan forming
Pharmadule Morimatsu AB with head office in Stockholm
Sweden.
Pharmadule Morimatsu is continuing the success Pharmadule AB has
had as the world leader in modular facilities. Since 1986, more
than 60 production facilities have been successfully delivered to
the pharmaceutical and biopharmaceutical industries worldwide
utilizing Pharmadule's unique modular concept.